With 37 new spin-offs, ETH Zurich continues its long-term upward trend in the launch of new companies from its research.

Swiss startup Oxyle announced a $16m funding round to scale its breakthrough solution to destroy, not just relocate, PFAS from wastewater. This builds on its $3M pre-seed round in 2022, growing ...

The Mission for Essential Drugs and Supplies (MEDS) in Kenya and CHAN Medi-Pharm in Nigeria, as well as Ecumenical Pharmaceutical Network (EPN) have joined forced with Swiss startup Axmed to improve ...

Legacy financial institutions, such as Germany’s oldest bank, Bankhaus Metzler, and global asset manager BlackRock, are integrating solutions from Swiss fintech startups to boost efficiency. Meanwhile ...

Yokoy, the leading spend management platform, has been acquired by TravelPerk, a business travel platform based in Barcelona. In parallel, TravelPerk announced the closing of a financing round in ...

Helix Robotics is developing the first commercial soft robot manipulator, addressing the need for human-friendly and reliable robotics. By combining the safety of soft robotics with industrial ...

According to the recently published Venture Kick Annual Report, the philanthropic initiative has backed 1,121 Swiss startup projects with CHF 80 million from private donors since its launch in 2007.

Over the past two years, Voltiris has reached significant milestones, including 12 commercial projects with renowned growers in Europe, partnerships with leading energy utilities such as Elektra ...

Major companies in the automotive, energy and agriculture sector are relying on Swiss startups to reach their CO2 emissions targets, achieve efficiency in electricity network monitoring and enable ...

Several Swiss start-ups have secured the necessary funds to conquer global markets.

Recent startup challenges are offering new platforms for startups to showcase and advance their solutions. Elythor and Prometheus are competing for a €100,000 grand prize in the HelloTomorrow ...

BioVersys started the offer period of its newly issued shares. Based on the offer price, the implied market capitalization of BioVersys is about CHF 212.9 million. Listing and first day of trading on ...